University of Virginia Health System May 8 2025 UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially less likely to develop the memory-robbing condition. The researchers, led by UVA's Jayakrishna Ambati, MD, previously identified a possible mechanism by which the drugs could prevent Alzheimer's. That promising finding prompted them to analyze two of